![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | A61K 38/18 | (2006.01) |
C07K 14/50 | (2006.01) | ||
C12N 1/21 | (2006.01) | ||
C12N 5/10 | (2006.01) | ||
C12N 15/18 | (2006.01) | ||
C12N 15/63 | (2006.01) | ||
A61K 47/48 | (2006.01) |
(11) | Patento numeris | 2068909 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 08732507.2 |
Europos patento paraiškos padavimo data | 2008-03-19 | |
(97) | Europos patento paraiškos paskelbimo data | 2009-06-17 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2012-04-25 |
(46) | Apibrėžties vertimo paskelbimo data | 2012-08-27 |
(86) | Numeris | PCT/US2008/057563 |
Data | 2008-03-19 |
(87) | Numeris | WO 2008/121563 |
Data | 2008-10-09 |
(30) | Numeris | Data | Šalis |
921297 P | 2007-03-30 | US | |
988060 P | 2007-11-14 | US |
(72) |
CUJEC, Thomas, P., US
MARIANI, Roberto, US
HAYS PUTNAM, Anna-maria, A., US
KEEFE, William, M., US
KNUDSEN, Nick, US
HO, Lillian, US
PINKSTAFF, Jason, US
KRAYNOV, Vadim, US
|
(73) |
Ambrx, Inc.,
10975 North Torrey Pines Road, Suite 100, La Jolla CA 92037,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Modifikuoti FGF-21 polipeptidai ir jų panaudojimas |
MODIFIED FGF-21 POLYPEPTIDES AND THEIR USES |
Mokėjimo data | Galiojimo metai | Suma | |
2024-02-20 | 17 | 347.00 EUR |
2025-03-19 |